| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addition of pioglitazone to stable insulin therapy in patients with poorly controlled type 2 diabetes: results of a double-blind, multicentre, randomized study
|
Davidson, J. A.
|
|
2006
|
|
2 |
p. 164-174
|
artikel
|
| 2 |
Association between antipsychotic drugs and diabetes
|
Holt, Richard I. G.
|
|
2006
|
|
2 |
p. 125-135
|
artikel
|
| 3 |
A triumph for physiology driving drug discovery: the potential impact of dipeptidyl peptidase-IV inhibitors in type 2 diabetes
|
|
|
2007
|
|
2 |
p. 151-152
|
artikel
|
| 4 |
Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial
|
Derosa, G.
|
|
2006
|
|
2 |
p. 197-205
|
artikel
|
| 5 |
Dipeptidyl peptidase-IV inhibitors: a major new class of oral antidiabetic drug
|
Idris, Iskandar
|
|
2007
|
|
2 |
p. 153-165
|
artikel
|
| 6 |
Does ethnic origin have an independent impact on hypertension and diabetic complications?
|
Baskar, V.
|
|
2006
|
|
2 |
p. 214-219
|
artikel
|
| 7 |
Double-blind, randomized, multicentre study of the efficacy and safety of gliclazide-modified release in the treatment of Chinese type 2 diabetic patients
|
Lu, C.-H.
|
|
2006
|
|
2 |
p. 184-191
|
artikel
|
| 8 |
Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and β-cell function in patients with type 2 diabetes
|
Brazg, R.
|
|
2007
|
|
2 |
p. 186-193
|
artikel
|
| 9 |
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial
|
Nauck, M. A.
|
|
2007
|
|
2 |
p. 194-205
|
artikel
|
| 10 |
Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetes
|
Rosenstock, J.
|
|
2007
|
|
2 |
p. 175-185
|
artikel
|
| 11 |
Metformin-glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy
|
Garber, A.
|
|
2006
|
|
2 |
p. 156-163
|
artikel
|
| 12 |
News and Views
|
Holt, Richard I. G.
|
|
2006
|
|
2 |
p. 234-236
|
artikel
|
| 13 |
News and Views
|
Holt, Richard I. G.
|
|
2007
|
|
2 |
p. 206-208
|
artikel
|
| 14 |
Opportunities for gene therapy in preventing vein graft failure after coronary artery bypass surgery
|
Baker, Andrew H.
|
|
2006
|
|
2 |
p. 119-124
|
artikel
|
| 15 |
Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients
|
Finer, N.
|
|
2006
|
|
2 |
p. 206-213
|
artikel
|
| 16 |
Protein kinase B/Akt signalling is required for palmitate-induced β-cell lipotoxicity
|
Higa, M.
|
|
2006
|
|
2 |
p. 228-233
|
artikel
|
| 17 |
Reactive species and early manifestation of insulin resistance in type 2 diabetes
|
Fridlyand, L. E.
|
|
2006
|
|
2 |
p. 136-145
|
artikel
|
| 18 |
Subnormal energy expenditure: a putative causal factor in the weight gain induced by treatment of hyperthyroidism
|
Jacobsen, R.
|
|
2006
|
|
2 |
p. 220-227
|
artikel
|
| 19 |
The serum levels of proinsulin and their relationship with IGFBP-1 in obese children
|
Kamoda, T.
|
|
2006
|
|
2 |
p. 192-196
|
artikel
|
| 20 |
Tissue-specific regulation of malonyl-CoA decarboxylase activity in OLETF rats
|
Kim, H. J.
|
|
2006
|
|
2 |
p. 175-183
|
artikel
|
| 21 |
Use of packaged entrees as part of a weight-loss diet in overweight men: an 8-week randomized clinical trial
|
Hannum, S. M.
|
|
2006
|
|
2 |
p. 146-155
|
artikel
|
| 22 |
Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo-controlled study *
|
Garber, A. J.
|
|
2007
|
|
2 |
p. 166-174
|
artikel
|
Tijdschrift beschrijving